Find the latest news on Coya Therapeutics
News
The ALS Association, Muscular Dystrophy Association, and ALS Finding a Cure Provide Additional Funding for Novel ALS Research |
![]() |
Coya Raises $10M to Advance T-cell Therapy Now in Phase 2 ALS Trial |
![]() |
Senior AbbVie liaison quits job to launch neuro startup, with sights set on ALS |
![]() |
Press Releases
Apr 27, 2022
Coya Therapeutics Announces Annals of Neurology Publication Featuring Biomarker Data in ALS Patients Treated with Tregs Cell Therapy
|
![]() |
Apr 22, 2022
Coya Therapeutics to Participate in B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference
|
![]() |
Dec 10, 2021
Coya Therapeutics Applauds U.S. House of Representatives for Passing ACT for ALS
|
![]() |
Blog
Jun 28, 2021
The Forest Fire Behind Neurodegenerative Diseases
|
![]() |
Jun 07, 2021
My Personal Journey to a Cure for ALS
|
![]() |
Apr 28, 2021
A Serendipitous Moment
|
![]() |
PRESENTATIONS
Events
Jun 11, 2021
Houston, TX., June 11, 2021 -- Coya Therapeutics, Inc., (Coya™), a clinical-stage biotechnology... |